BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17229336)

  • 1. Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment.
    Anagnostopoulos A; Zervas K; Kyrtsonis M; Symeonidis A; Gika D; Bourantas K; Zomas A; Anagnostopoulos N; Pangalis G; Dimopoulos MA;
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):205-9. PubMed ID: 17229336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Hamilos G; Zervas K; Symeonidis A; Kouvatseas G; Roussou P; Gika D; Karmiris T; Bourantas K; Zomas A; Mitsouli C; Xilouri I; Vervessou E; Matsis K; Anagnostopoulos N; Economopoulos T;
    Ann Oncol; 2003 Aug; 14(8):1299-305. PubMed ID: 12881396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.
    Dimopoulos M; Gika D; Zervas K; Kyrtsonis M; Symeonidis A; Anagnostopoulos A; Bourantas K; Matsouka C; Pangalis G
    Leuk Lymphoma; 2004 Sep; 45(9):1809-13. PubMed ID: 15223640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic Waldenstrom's macroglobulinemia.
    Alexanian R; Weber D; Delasalle K; Cabanillas F; Dimopoulos M
    Semin Oncol; 2003 Apr; 30(2):206-10. PubMed ID: 12720137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waldenström's macroglobulinemia.
    Dimopoulos MA; Anagnostopoulos A
    Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.
    Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA
    Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of advanced age according to IPSSWM cut-off on the outcome of symptomatic and asymptomatic Waldenström's macroglobulinemia at diagnosis.
    Ricci F; Tedeschi A; Vismara E; Greco A; Montillo M; Nichelatti M; Varettoni M; Lazzarino M; Morra E
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):124-6. PubMed ID: 21454211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia.
    Cho JH; Shim JH; Yoon SE; Kim HJ; Kim SH; Ko YH; Lee ST; Kim K; Kim WS; Kim SJ
    Korean J Intern Med; 2021 May; 36(3):668-678. PubMed ID: 32791817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in China.
    Cao XX; Yi SH; Jiang ZX; He JS; Yang W; Du J; Sun CY; Wu Y; Chen WM; Liu XJ; Li BZ; Li CR; Sang W; Liu QH; Chu XX; Li F; Bai O; Mao M; Fu R; Wang W; Liu LH; Wang LQ; Dong YJ; Luo J; Li ZL; Wei YQ; Zhang QK; Liu J; Ding KY; Zou L; Chen BY; Hua LM; Jing HM; He J; Wang L; Li J; Qiu LG
    Leuk Lymphoma; 2021 Nov; 62(11):2657-2664. PubMed ID: 34105439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
    Kyle RA; Ansell SM; Kapoor P
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating low CD4
    Cao X; Kong YL; Wang L; Liang JH; Xia Y; Zhu HY; Fan L; Jiang SH; Liu H; Li JY; Xu W
    Ann Hematol; 2021 Apr; 100(4):995-1002. PubMed ID: 33651193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Waldenström's macroglobulinemia with an uncommon presentation].
    Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
    Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
    Björkholm M; Johansson E; Papamichael D; Celsing F; Matthews J; Lister TA; Rohatiner AZ
    Semin Oncol; 2003 Apr; 30(2):226-30. PubMed ID: 12720141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
    J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
    Kastritis E; Zervas K; Repoussis P; Michali E; Katodrytou E; Zomas A; Simeonidis A; Terpos E; Delimbassi S; Vassou A; Gika D; Dimopoulos MA;
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):50-2. PubMed ID: 19362972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
    Cesana C; Miqueleiz S; Bernuzzi P; Tresoldi E; Rossi V; D'avanzo G; Filippini D; Morra E
    Semin Oncol; 2003 Apr; 30(2):231-5. PubMed ID: 12720142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to manage Waldenstrom's macroglobulinemia.
    Buske C; Leblond V
    Leukemia; 2013 Apr; 27(4):762-72. PubMed ID: 23385376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.